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Introduction
The ability of animal cells to change their shape is essential for 
diverse processes from cell division to tissue remodeling during 
development, homeostasis, and disease (Rungger-Brändle and 
Gabbiani,  1983;  Lecuit  and  Lenne,  2007;  St  Johnston  and   
Ahringer, 2010). Moreover, for specialized cell types such as blood 
cells and neurons (Tahirovic and Bradke, 2009; Diez-Silva et al., 
2010), dynamic form plays a critical role in cellular physiology. 
In all cases, forces generated by cortical actin filament dynam-
ics and by the ATP-dependent movement of myosin motors 
along filaments play key roles in reshaping cells (Pollard, 2007). 
Generating a form appropriate to function therefore depends on 
local remodeling of the actin–myosin network driven by signals 
from the environment as well as the complement of actin acces-
sory proteins expressed by a given cell.
The core actin cytoskeletal regulators are surprisingly well 
conserved across diverse species from yeast to humans. These 
include actin itself; two conserved filament nucleation pathways, 
one mediated by formins and the other by Arp2/3; regulators of 
filament dynamics such as profilin, capping protein, and cofilin; 
and upstream regulators, such as Ste20 family kinases and small 
Rho GTPases (Cvrcková et al., 2004; Rohn and Baum, 2010). 
Much of our knowledge about actin regulation in metazoan or-
ganisms relies on extrapolations from work done in yeast and on 
data from biochemical studies in a variety of systems. Further-
more, metazoan genomes encode a large number of conserved 
A
lthough a large number of actin-binding proteins 
and their regulators have been identified through 
classical approaches, gaps in our knowledge re-
main.  Here,  we  used  genome-wide  RNA  interference   
as a systematic method to define metazoan actin regula-
tors based on visual phenotype. Using comparative screens 
in cultured Drosophila and human cells, we generated 
phenotypic  profiles  for  annotated  actin  regulators  to-
gether with proteins bearing predicted actin-binding do-
mains. These phenotypic clusters for the known metazoan 
“actinome” were used to identify putative new core actin 
regulators, together with a number of genes with con-
served but poorly studied roles in the regulation of the 
actin cytoskeleton, several of which we studied in detail. 
This  work  suggests  that  although  our  search  for  new 
components of the core actin machinery is nearing satu-
ration, regulation at the level of nuclear actin export, 
RNA splicing, ubiquitination, and other upstream pro-
cesses remains an important but unexplored frontier of 
actin biology.
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DNA (see Materials and methods for details). After filtering 
and annotating hits with a controlled vocabulary, we identified 
a number of broad phenotypic categories (Fig. 1, C and D; see 
Table S2 for all hit annotations). The largest of these was the 
“viability” cluster, where gene silencing resulted in a consider-
able reduction in cell number. These genes were eliminated 
from the morphological analysis, except where evidence was 
available that interacting proteins displayed similar phenotypes 
(as for the SCF complex, described later).
As expected, many hits in this visual screen were previ-
ously identified as having a reduced cell area as a result of growth 
and/or adhesion defects in an automated image analysis of the 
same dataset (Jani and Schöck, 2007; Sims et al., 2009). A cluster 
of dsRNAs induced a multinucleate phenotype associated with 
cytokinesis defects (Echard et al., 2004; Eggert et al., 2004). Of 
these, 17 were hits in previous studies, such as Rho (Rho1), 
Myosin II/MHC (zipper), and Anillin (scraps). Another cluster 
of dsRNAs induced various microtubule phenotypes, including 
various tubulin genes, the known microtubule regulator Tao-1 
(Liu et al., 2010), dynein heavy chain (Dhc64C; Rasmusson et al., 
1994), and nine eukaryotic initiation factor genes (Table S2).
The remaining 143 dsRNAs induced defects in the actin 
cytoskeleton—the focus of this study (Table S2). Of these,   
22 were already known to be involved in the regulation of actin 
filament dynamics. These included representatives of the core 
conserved actin machinery previously described, including sev-
eral  actins  (these  are  95%  identical  in  Drosophila),  Profilin 
(chic), Capping protein (cpa and cpb subunits), Cofilin (twin-
star), and three members of the Arp2/3 complex. Other known 
actin regulators identified as hits in our screen included the Rho 
family GTPases Rac1, Rac2, and Cdc42, along with all known 
members of the SCAR complex (SCAR, Abi, Hem, Sra-1) ex-
cept the HSPC300 subunit (Kunda et al., 2003; Rogers et al., 
2003), which all share a spiky cell phenotype (Table S2). Sig-
nificantly, this Rac/SCAR-like spiky phenotypic cluster included 
another ten dsRNAs targeting nine genes not previously linked 
to Rac/SCAR signaling. Furthermore, a further set of genes had 
spiky morphology after RNAi silencing similar to that of SCAR, 
although with a range of additional subtle differences that led   
us to assign them to a distinct category. This alternative spiky   
cluster included clathrin heavy chain (Chc), which was recently 
characterized as having a role in SCAR-mediated lamellipodia 
formation independent from its role in vesicle trafficking 
(Gautier et al., 2011).
Our set of 143 putative actin regulators also contained 
two large clusters characterized by altered levels of actin fila-
ments (Table S2). The “high phalloidin” cluster included actin- 
capping protein (cpa and cpb), whose knockdown is known to 
lead to an increase in F-actin (Kiger et al., 2003; Rogers et al., 
2003), whereas the “low phalloidin” class included several   
actin genes (Act42A, Act5C, Act87E) and Profilin (chic). How-
ever, because the overall intensity of actin staining was vari-
able across plates and was affected by cell density, we chose 
not to include these two clusters in our further analysis. In-
stead, in addition to the spiky cluster, we focused on dsRNAs 
giving rise to an assortment of rarer actin-related phenotypes 
(category “other actin”), including an increase in intracellular 
genes of unknown function that contain protein domains known 
to bind to or regulate actin. In this study our goal was to extend 
this work by using RNAi screening to better define a conserved 
metazoan “actinome” based upon gene function.
In recent years, with the development of high-throughput 
RNAi screening in cell culture, it has become possible to search 
in an unbiased fashion for new players involved in a variety of 
cell biological processes (Echeverri and Perrimon, 2006). Previ-
ous screens have used RNAi to define regulators of Drosophila 
cell shape (Kiger et al., 2003) and to identify novel components 
of the SCAR complex (Kunda et al., 2003; Rogers et al., 2003), 
whereas other groups used RNAi together with automated com-
putational approaches to screen for clusters of actin regulators 
(Bakal et al., 2007). More recently, Fuchs et al. (2010) applied 
genome-wide RNAi screening and automated image analysis to 
survey genes regulating the shape of human HeLa cells, whereas 
D’Ambrosio and Vale (2010) used an automated analysis in   
a genome-wide screen to study cell spreading in Drosophila  
S2 cells. Although automating the image analysis speeds up an-
notation, minimizes user bias, and generates quantitative data, 
the trained human eye is still superior when searching for novel 
and subtle phenotypes. Indeed, it remains a mainstay for many 
types of screen (Eggert et al., 2004; Sönnichsen et al., 2005; 
Schnorrer et al., 2010).
Here, to identify a core set of actin regulators, we per-
formed a visual genome-wide RNAi screen in Drosophila S2R+ 
cells,  and  a  more  focused  screen  in  human  HeLa  cells.  By   
comparing the orthologous human and fly RNAi datasets, we 
were able to eliminate genes from our analysis with cell type– 
or species-specific functions and to limit the number of genes 
identified with an indirect effect on the actin cytoskeleton. We 
then followed up a subset of the hits. This analysis identified a 
set of novel, conserved regulators of the actin cytoskeleton, in-
cluding components of the Skp1-Cul1-F-box-protein (SCF) E3 
ubiquitin ligase complex, the spliceosome and genes affecting 
the formation of actin filaments in the nucleus. The data suggest 
that although few previously uncharacterized core actin-binding 
proteins remain to be identified, understanding the complete 
picture of upstream regulation of actin cytoskeletal dynamics 
remains an important challenge. We further believe that this 
simple cross-species approach can be used as a simple, cheap, 
and effective way to screen for conserved regulators of a wide 
number of cell biological processes.
Results
A genome-wide Drosophila RNAi screen  
for cell morphology
RNA interference enables systematic loss-of-function screens 
across a genome (Mohr et al., 2010). Our goal was to use parallel 
cell-based RNAi screens in fly and human cell culture to gain   
a  more  comprehensive  picture  of  metazoan  actin  regulators   
and their phenotypes. To do so, we first performed a genome-
wide, high-content RNAi screen in the hemocyte-derived ad-
herent Drosophila cell line S2R+ (Fig. 1, A and B; Table S1;   
Yanagawa et al., 1998), whose read-out was a visual inspection 
of images of fixed cells stained with -tubulin, F-actin, and 791 Screens define the conserved metazoan actinome • Rohn et al.
Donaldson et al., 2004; Reynolds et al., 2008). We inspected the 
original screen images to determine whether other genes in the 
complex were identified by phenotype. It was clear from this 
analysis that, despite having a reduced cell number, Cul-4 and 
Roc1a manifested the same spiky, Rac/SCAR-like phenotype, 
so these genes were annotated accordingly. In contrast, dsRNAs 
targeting other complex members including Cul-2, Cul-3, Cul-5, 
and SkpA were indistinguishable from controls.
Based upon this analysis of the screen data, we selected a 
subset of genes for further validation: (1) 38 genes with strong 
actin-related phenotypes (spiky or “other” annotations), which 
included novel genes along with core known genes; and (2)   
8 representative genes with a nuclear actin phenotype (Table I). 
To  exclude  the  possibility  of  sequence-specific  off-target   
effects (Perrimon and Mathey-Prevot, 2007), we retested each of 
our chosen hits and their interactors using a second independent 
dsRNA (Table S2). From group I, 36/38 genes were confirmed 
as hits, including additional Arp2/3 genes and the extra SCF genes, 
and 6/8 group II genes were successfully validated (Table I). These 
included genes with a known function in the export of actin 
monomers from the nucleus, namely chic and Exp6 (Stüven   
et al., 2003).
actin structures such as stress fibers or cytoplasmic speckles 
and/or changes in the level or organization of peripheral actin. 
This set included Pak3, which we previously characterized as 
an actin regulator (Asano et al., 2009), and the WH2 motif con-
taining  adenylate  cyclase-associated  protein  Capulet/Act  up 
(Capt; Baum et al., 2000; Benlali et al., 2000). In addition, a 
cluster of 29 genes was characterized by a novel phenotype in 
which actin filaments accumulated as a bar or cable-like struc-
ture within the nucleus.
Next,  we  used  hierarchical  clustering  tools  within  the 
FLIGHT database to reveal hits with similar phenotypes form-
ing part of the same interaction network or protein complex. 
This analysis revealed a prominent cluster with spiky morphol-
ogy containing slmb (supernumerary limbs), lin19, and Roc1b, 
all of which are members of the same well-characterized com-
plex, the SCF family of E3 ubiquitin ligases. Roc1b is a RING 
domain–containing protein that facilitates transfer of charged 
ubiquitin from the E2 ligase; Lin19 is a member of the cullin 
scaffold family, whereas Slmb is a member of the F-box family 
of proteins, which select protein targets for ubiquitination by 
the  SCF  complex  (Jiang  and  Struhl,  1998;  Deshaies,  1999; 
Bocca et al., 2001; Noureddine et al., 2002; Ou et al., 2002; 
Figure 1.  Screen overview. (A) A genome-wide morphology RNAi screen was performed in Drosophila S2R+ cells and in a subset of human HeLa cells 
for genes corresponding to a comprehensive set of all known human actin regulatory genes and genes predicted to play a role based on their domain 
structure. Comparing the two screens we were able to cluster the hits into morphological groups and arrive at a shortlist of conserved known and new actin 
regulatory genes. (B) A flowchart of the methodology. (C) Breakdown of all Drosophila hits by dominant phenotype; many hits fell into multiple categories, 
but these have only been accounted for in one category in this graph (see Table S2 for details). (D) Fly and (E) human hits clustered as a heat map; red 
indicates a hit in the specified category.JCB • VOLUME 194 • NUMBER 5 • 2011   792
Table I. Final list of genes with actin phenotypes conserved between Drosophila and mammalian cells
FBgn Gene Phenotype 
group
Known actin 
regulator
Validated Function Mammalian 
orthologue(s)
HeLa actinome 
hit(s)
Mouse nuclear 
hit(s)
FBgn0015610 Caf1 High actin No Yes Chromatin  
remodeling
RBBP4 No N/A
FBgn0034577 cpa High actin Yes Yes F-actin  
capping
CAPZA1, CAPZA2, 
CAPZA3
CAPZA1, 
CAPZA3
N/A
FBgn0011570 cpb High actin Yes Yes F-actin capping CAPZB CAPZB N/A
FBgn0000042 Act5C Low actin Yes Yes Actin filament  
formation
ACTG1 ACTG1 N/A
FBgn0000308 chic Low actin Yes Yes G-actin  
binding
PFN1, PFN2,  
PFN3, PFN4
PFN1, PFN4 
(PFN3 not 
screened)
N/A
FBgn0011785 BRWD3 Other actin No Yes WD40 domain 
protein
BRWD1,BRWD3,  
PHIP
No N/A
FBgn0028388 Capt Other actin Yes Yes G-actin binding CAP1, CAP2 No N/A
FBgn0035586 CG10671 Other actin No No Endoplasmic  
reticulum
FITM1, FITM2 No N/A
FBgn0039205 CG13623 Other actin No Yes Mitochondrial ISCA2 (HBLD1) ISCA2 N/A
FBgn0001491 L(1)10Bb Other actin No Yes GPCR signaling BUD31 (G10) BUD31 N/A
FBgn0044826 Pak3 Other actin Yes Yes Rac GTPase  
signaling
PAK3 No N/A
FBgn0021967 Pdsw Other actin No No Mitochondial  
electron transport 
chain
NDUFB10 No N/A
FBgn0011726 tsr Other actin Yes Yes F-actin severing CFL1, CFL2,  
DSTN
CFL1, DSTN N/A
FBgn0052138 CG32138 Spiky Moderately Yes Uncharacterized  
formin family 
member
FMNL1, FMNL2, 
FMNL3
FMNL1 N/A
FBgn0002183 dre4 Spiky No Yes DNA repair SUPT16H SUPT16H N/A
FBgn0015509 lin19 Spiky No Yes Ubiquitin- 
dependent protein 
degradation
CUL1 Not screened N/A
FBgn0040291 Roc1b Spiky No Yes Ubiquitin- 
dependent protein 
degradation
RBX1 RBX1 N/A
FBgn0003415 skd Spiky No Yes Mediator complex MED13,  
MED13L
No N/A
FBgn0005411 U2af50 Spiky No Yes RNA splicing U2AF2 U2AF2 N/A
FBgn0020510 Abi Spiky  
(SCAR-like)
Yes Yes SCAR complex ABI1, ABI2 No N/A
FBgn0031781 Arc-p20
a Spiky  
(SCAR-like)
Yes Yes ARP2/3 complex ARPC4 ARPC4 N/A
FBgn0011742 Arp14D Spiky  
(SCAR-like)
Yes Yes ARP2/3 complex ACTR2 No N/A
FBgn0011744 Arp66B Spiky  
(SCAR-like)
Yes Yes ARP2/3 complex ACTR3 No N/A
FBgn0039754 CG9747 Spiky  
(SCAR-like)
No Yes Fatty acid  
desaturase
SCD, SCD5,  
TRMT2A, TRMT2B
SCD (only one 
screened)
N/A
FBgn0011771 Hem Spiky  
(SCAR-like)
Yes Yes SCAR complex NCKAP1 NCKAP1 N/A
FBgn0031437 p16-arc Spiky  
(SCAR-like)
Yes Yes ARP2/3 complex ARPC5 No N/A
FBgn0010333 Rac1 Spiky  
(SCAR-like)
Yes Yes Rho family  
GTPase
RAC1 RAC1 N/A
FBgn0014011 Rac2 Spiky  
(SCAR-like)
Yes Yes Rho family  
GTPase
RAC2 No N/A
FBgn0041781 SCAR Spiky  
(SCAR-like)
Yes Yes SCAR complex WASF1, WASF2, 
WASF3
WASF3 N/A
FBgn0016984 Sktl Spiky  
(SCAR-like)
Yes Yes Lipid kinase PIPK51A, PIPK51B, 
PIPK51C
PIP5K1C N/A
aSpiky (SCAR-like) annotation added after re-assessment with a longer RNAi period. See text for details.
bSpiky (SCAR-like) annotation added after network analysis and reassessment. See text for details.793 Screens define the conserved metazoan actinome • Rohn et al.
A and B, profilin, cofilin, actin, Arp2/3, SCAR, nonmuscle myo-
sin II, Rac, Rho, and Cdc42. When comparing fly versus human 
phenotypes, some fly/human orthologous pairs had similar mor-
phological attributes; for example, both twinstar and CFL-1 de-
pletion caused increased peripheral F-actin and multinucleated 
cells; and both cpb and CAPZB silencing induced a dramatic in-
crease in F-actin levels (Fig. 2). In contrast, others gene pairs 
manifested  different  phenotypes  (e.g.,  Act5C/ACTG1  and 
SCAR/WASF3; Fig. 2). These differences are likely due to cell- 
and  species-specific  differences  in  the  interaction  networks 
controlling cell shape.
We  then  inspected  phenotypes  for  mammalian  homo-
logues  of  our  novel  validated  Drosophila  hits  (Table  I;  see   
Table S4 for individual annotations and Fig. 1 E for their pheno-
typic clustering). For this analysis we used human siRNAs in 
HeLa cells, with the exception of the small cluster manifesting 
actin bars in the nucleus, for which we depleted the mouse   
orthologues in murine R3A4 cells. This analysis identified eight 
human orthologues of the fly hits together with two genes not 
previously implicated in nuclear actin regulation (Table I; dis-
cussed in detail later).
The eight pairs of conserved fly/human hits represent a 
diverse range of predicted cellular processes (Fig. 3, A–C). 
Identification of a conserved set  
of actin regulators
This analysis in Drosophila cells identified phenotypic profiles 
for the entire set of known actin regulators along with poorly 
characterized or unknown genes bearing actin-binding domains, 
and also identified a set of potentially novel actin regulators. To 
determine which of these genes perform conserved functions 
across species and cell types, we wanted to expand the analysis 
to a mammalian system. As a framework for the analysis of 
functional conservation of putative novel actin regulators, we 
therefore generated phenotypic profiles for the entire set of known 
mammalian actin regulators for comparison. To do so, we per-
formed a duplicate siRNA screen of 516 known or predicted   
actin and Rho-GTPase family regulators (the “actinome”; 
Table S3) in human HeLa cells (Fig. 1, A and B). In addition, 
we tested the functions of representative close human ortho-
logues of the set of putative novel actin regulators identified in 
the fly screen (Table I). 116 genes from this set were annotated as 
hits (Table S4), based upon having a reproducible phenotype 
with ≥2 individual siRNAs.
Comparison of the results of the S2R+ and HeLa screens 
revealed several hits among orthologous actin regulators (see 
Fig. 2 for representative images), including capping proteins   
FBgn Gene Phenotype 
group
Known actin 
regulator
Validated Function Mammalian 
orthologue(s)
HeLa actinome 
hit(s)
Mouse nuclear 
hit(s)
FBgn0023423 slmb Spiky  
(SCAR-like)
No Yes Ubiquitin- 
dependent protein 
degradation
BTRC,  
FBXW11
Not screened N/A
FBgn0038320 Sra-1 Spiky  
(SCAR-like)
Yes Yes SCAR complex CYFIP1,  
CYFIP2
CYFIP1 N/A
FBgn0032859 Arc-p34 Spiky  
(SCAR-like)
a
Yes Yes ARP2/3 complex ARPC2 ARPC2 N/A
FBgn0038369 Arpc3a Spiky  
(SCAR-like)
a
Yes Yes ARP2/3 complex ARPC3A No N/A
FBgn0065032 Arpc3b Spiky  
(SCAR-like)
a
Yes Yes ARP2/3 complex ARPC3B No N/A
FBgn0001961 Sop2 Spiky  
(SCAR-like)
Yes Yes ARP2/3 complex ARPC1A,  
ARPC1B
ARPC1A N/A
FBgn0033260 Cul-4 Spiky  
(SCAR-like)
b
No Yes ubiquitin- 
dependent protein 
degradation
CUL4A,  
CUL4B
Not screened N/A
FBgn0025638 Roc1a Spiky  
(SCAR-like)
b
No Yes ubiquitin- 
dependent protein 
degradation
RBX1 RBX1 N/A
FBgn0022213 Cas Nuclear actin No Yes Nuclear transport Cse1l N/A No
FBgn0030121 CG17446 Nuclear actin No Yes Transcription Cxxc1 N/A No
FBgn0031492 CG3542 Nuclear actin No No Splicing Prpf40a,  
Prpf40b
N/A N/A
FBgn0037093 CG7597 Nuclear actin No Yes Splicing (kinase) Crkrs,  
Cdc2l5
N/A Cdc2l5 (Crkrs 
not tested)
FBgn0001337 Exp6 Nuclear actin Yes Yes Nuclear transport Xpo6 N/A Yes
FBgn0037657 hyx Nuclear actin No Yes Transcription Cdc73 N/A Yes
FBgn0016696 Pitslre Nuclear actin No No Splicing (kinase) Cdc2l1 N/A N/A
FBgn0003449 snf Nuclear actin No Yes Splicing Snrpa,  
Snrpb2
N/A Too toxic  
to assess
aSpiky (SCAR-like) annotation added after re-assessment with a longer RNAi period. See text for details.
bSpiky (SCAR-like) annotation added after network analysis and reassessment. See text for details.
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Figure 2.  Images of representative conserved core fly/human gene pairs. Grayscale panels, F-actin; color panels, red is F-actin, green is -tubulin, blue 
is DNA. In the case of human siRNAs, the representative siRNA ID number is indicated in the label. Bar, 50 µm.795 Screens define the conserved metazoan actinome • Rohn et al.
Figure 3.  Images of conserved novel fly/human gene knockdown pairs. Color and siRNA labeling as in Fig. 2. The fly gene phenotypes manifested best 
under different conditions: (A) fixed after respreading on concanavalin A–coated surface; (B) fixed after respreading on serum-coated surfaces; or (C) fixed 
after continuous growth under RNAi, no respreading. Bar, 50 µm. On the right is a brief description of the known or predicted function of each set of genes.JCB • VOLUME 194 • NUMBER 5 • 2011   796
The FACT complex (Belotserkovskaya et al., 2003) is a 
heterodimeric complex involved in the modulation of chromatin 
assembly to influence gene expression, including Hox genes 
(Shimojima et al., 2003). One of its subunits, SPT16, was an 
actin hit in this category. Depletion of the Drosophila dre4/
dSPT16 gene in fly cells or its human orthologue, SupT16H 
(SPT16)  in  HeLa  cells  caused  an  elongated  cell  shape  and 
changes in peripheral actin levels in both cell types.
CG9747 is an unstudied fly gene, but one of its human   
orthologues,  SCD  (SCD1;  stearoyl-CoA  desaturase  [delta-9- 
desaturase]), is an enzyme involved in the formation of saturated 
fatty acids (Igal, 2010). In our screen, depletion of CG9747 
caused a spiky cell shape and increased actin puncta in S2R+ 
cells, whereas in HeLa cells, SCD knockdown led to an increase 
in actin stress fibers, a variable cell shape ranging from elon-
gated to geometric, and an increase in multinucleated cells.
The final gene pair in this category, Roc1a/RBX1, which 
we studied in more detail, is described fully in the next section.
The SCF ubiquitin ligase pathway plays  
a role in cell shape
Components of the Rac/SCAR pathway, including its upstream 
regulators, Rac and Cdc42, the SCAR complex itself, and its 
downstream target, the Arp2/3 complex, which drives actin nu-
cleation, were previously identified as having a common “spiky” 
RNAi phenotype in fly cells resulting from the loss of lamelli-
podia (Kunda et al., 2003; Rogers et al., 2003; see Fig. 4 A).   
RNAi-mediated  depletion  of  the  orthologous  gene  products 
from HeLa cells leads to a related phenotype, in which cells 
lose lamellipodia, take on a large geometrical shape, and accu-
mulate stress fibers (Fig. 4 A; Innocenti et al., 2004; Derivery   
et al., 2008). This readout provided us with a useful assay for 
uncovering novel conserved components of this signaling path-
way, and our parallel RNAi screening approach revealed several 
conserved genes were whose knockdown recapitulated the Rac/
SCAR phenotype in both systems. This included five members 
of the SCF complex.
The core SCF complex recruits its substrate via an F-box 
receptor protein. Although our data suggested that slmb served 
that function, we wanted to inspect the phenotypes of all other 
F-box genes in our fly screening data. Drosophila has 37 mem-
bers with domains characteristic of the F-box group (Ho et al. 
[2006] have reported 31), but slmb was the only one with a 
spiky phenotype. Although it is certainly possible that not all of 
these genes were efficiently depleted in the screen, these obser-
vations are consistent with Slmb being the sole or major F-box 
protein involved in the SCF-mediated actin phenotype in our 
system. Having validated these hits using independent RNAi 
reagents (Fig. 4 B shows representative examples), we chose to 
focus on a single component of this complex, Roc1a/RBX1, for 
the follow up analysis because silencing of this gene led to a   
robust loss of lamellipodia in S2R+ and HeLa cells (Fig. 4 A).
The stability of SCAR complex components (consisting 
in Drosophila of SCAR, Abi, Hem, Sra-1, and HSPC300) has pre-
viously been shown to be coordinately regulated by proteasome- 
dependent proteolysis, so that if one member of the complex is   
depleted by RNAi, the other components are also degraded 
We recovered only one pair, CG32138/FMNL1, among the 
many uncharacterized genes predicted by domain structure to 
be involved in actin regulation. Drosophila CG32138 is a previ-
ously uncharacterized member of the formin family of actin-
nucleating proteins (Goode and Eck, 2007) whose depletion 
was associated with an actin phenotype marked by a failure to 
spread, broken and disorganized lamellipodia, and multiple cyto-
plasmic actin cables, primarily positioned above the nucleus. 
Likewise, knockdown of FMNL1, one of the three human ortho-
logues of CG32138, which has only recently been characterized 
(Han et al., 2009; Mersich et al., 2010; Mason et al., 2011), also 
led to an accumulation of actin filaments in the apical cell body 
and lamellipodia with a serrated appearance.
Two  of  the  fly/human  hit  pairs,  l(1)10Bb/BUD31  and 
CG13623/ISCA2, were more unexpected. Fly l(1)10Bb RNAi 
caused a particularly striking phenotype on knockdown that 
was unique in our screen: extremely large actin clumps and bro-
ken, distorted lamellae. Depletion of its sole human orthologue, 
the highly conserved BUD31, also led to large actin clumps and 
disorganized lamellipodia. The Saccharomyces cerevisiae homo-
logue of this gene (also called BUD31) has been shown to be 
part of a splicing complex (Masciadri et al., 2004), and has been 
implicated in the splicing of actin and profilin transcripts. This 
effect is, however, unlikely to be a general consequence of   
aberrant RNA splicing because this striking phenotype is not 
shared by other splicing factors in fly cells (Table I) or in yeast 
(Masciadri et al., 2004). Even less is known about CG13623 
and its human orthologue ISCA2 (HBLD1), which are entirely 
uncharacterized proteins whose main distinguishing feature is 
the presence of a hesB/yadR/yfhF domain, which in bacteria is 
thought to play a role in the biogenesis of iron–sulfur clusters 
for electron transfer processes (Cózar-Castellano et al., 2004). 
In our experiments, depletion of CG13623 led to asymmetrical 
lamellipodia, clumps of actin, and occasionally transverse stress 
fibers. Similarly, with the human orthologue ISCA2, knock-
down led to polarized, peripheral clumps of actin in a flattened, 
roughly  geometric  shape,  with  the  frequent  occurrence  of  a 
thick actin bar at cell–cell junctions.
The five remaining gene pairs have been studied in other con-
texts. Skittles functions in phosphatidylinositol 4,5-bisphosphate 
production, and Xu et al. (2010) have demonstrated a role for the 
human  orthologue  PIP5K1C  (phosphatidylinositol-4-phosphate   
5-kinase type-1, also known as PIP5K1-gamma) in neutrophil 
polarity and adhesion. Depletion of these genes in both human 
and fly cells in our screen resulted in an elongated cell shape 
and an increase in actin puncta, which is consistent with the im-
portant role of PIP2 in the regulation of a large number of actin-
binding proteins (Yin and Janmey, 2003).
The human gene U2AF2 (also known as U2AF65) en-
codes the large subunit of the U2AF heterodimeric complex, 
which is involved in the initial steps of spliceosome assembly 
on preRNA (Mollet et al., 2006). In Drosophila, the ortholo-
gous large subunit U2AF50 has been additionally implicated in 
the  nuclear  export  of  intronless  mRNAs  (Blanchette  et  al., 
2004). In our screen, depletion of these two genes in both spe-
cies causes disorganized actin and multinucleated cells, perhaps 
indicative of a defect in cytokinesis.797 Screens define the conserved metazoan actinome • Rohn et al.
Figure 4.  The SCF ubiquitin ligase complex is involved in actin regulation. For all grayscale panels, staining is for F-actin. RBX1 and roc1a phenocopy 
the SCAR complex in human (A, top row) and fly (A, bottom row) cells. Bar, 50 µm. (B) Depletion of various SCF members phenocopies SCAR knockdown 
in fly cells. Bar, 20 µm. (C) roc1a/RBX1 depletion does not affect SCAR complex stability as measured by Sra1 or WASF2 protein levels in Western 
blot, respectively in fly cells (top) or human cells (bottom left), in the same situation when depleting other SCAR complex members does. Equal loading is 
indicated by tubulin staining of the same gels. The RBX1 knockdown in parallel cultures causes significant depletion (bottom right), with loading shown by 
staining for CDC2. (D) RacV12 overexpression (as marked by GFP, green; F-actin is red in top panels and grayscale in the bottom; blue is DAPI) rescues 
spiky phenotype of roc1a and slmb but not that of scar. Bar, 50 µm. (E) RacV12 overexpression (as marked by myc-tag, green; same staining for rest as 
in D) rescues RBX1 knockdown but not that of NCKAP1. Bar, 50 µm.
(Kunda et al., 2003; Rogers et al., 2003; Derivery et al., 2008). 
To determine whether Roc1a/RBX1 is involved in this process, 
we therefore silenced Roc1a in S2R+ cells and then tested for 
the presence of Sra-1 protein by Western blot, as a marker for 
whole SCAR complex stability. Although knockdown of Sra1, 
SCAR, or Hem led to decreased levels of Sra-1 protein as ex-
pected, levels of Sra-1 remained unchanged in Roc1a RNAi 
cells (Fig. 4 C, top), under conditions in which nearly all cells 
manifested the spiky phenotype. Similarly, in human cells, the 
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the downstream SCAR complex member NCKAP1 (Fig. 4 E). 
These data suggest that Rac can activate lamellipodial formation 
independently of Roc1a/RBX1; i.e., that Roc1a/RBX1 acts ge-
netically upstream of Rac function. As a second test of this   
hypothesis, we performed double knockdown of roc1a in S2R+ 
cells with Pak3, a gene whose knockdown phenotype resembles 
the expression of constitutively active Rac (Asano et al., 2009). 
Again this condition resulted in a partial rescue of the spiky   
phenotype (Fig. S1 D; note that Pak3 protein levels were un-
affected by Roc1a silencing, as shown in Fig. S1 E). Taken to-
gether, these data suggest that Roc1a protein exerts its effects 
upstream of Rac in a Pak3-independent manner.
To further confirm this genetic interaction between RBX1 
and the Rac pathway, we wanted to investigate whether endog-
enous activated Rac1 was reduced after depletion of RBX1. 
First, we used siRNA to deplete either Rac1 or RBX1 in HeLa 
cells. We then replated cells to stimulate Rac activity during re-
spreading over the course of 5 h, and performed a pull-down   
assay  using  beads  conjugated  to  the  PBD  domain  of  PAK, 
which specifically binds to the GTP-bound active form of Rac1. 
These experiments showed that levels of activated Rac1 were 
reduced to 36 ± 19% compared with overall Rac1 levels after 
RBX1 silencing (quantified in Fig. 5 A, with a representative 
Western blot shown in Fig. 5 B). Second, RBX1-depleted HeLa 
cells were stained with an antibody that targets the active, GTP-
bound form of Rac1 (Haralalka et al., 2011). In this experiment, 
the high levels of active Rac1 seen in the cytoplasm and at the 
edges of spreading control cells were dramatically reduced after 
both RBX1 and Rac1 depletion (Fig. S1 F). Taken together, 
these experiments support the hypothesis that RBX1 acts up-
stream of Rac1.
Hyx/Cdc73 and CG7597/Cdc2l5 knockdown 
lead to excess actin in the nucleus
As mentioned previously, among the hits causing defects in the 
organization  of  the  actin  cytoskeleton,  a  subset  displayed  a 
prominent phalloidin-stainable bar in the nucleus of S2R+ cells 
depleting RBX1, whereas knockdown of the Sra1 homologue 
CYFIP2 or the Hem homologue NCKAP1 led to degradation of 
WASF2 protein in HeLa cells (Fig. 4 C, bottom left), even though 
RBX1 levels were dramatically reduced after RNAi (Fig. 4 C,   
bottom right; the results of five replicate experiments in human 
and fly cells are quantified in Fig. S1 A). These results suggest 
that although the SCF complex regulates the stability of many 
targets and appears to regulate the formation of lamellipodial 
actin, it is unlikely to interfere directly with the stability of SCAR 
complex components.
Two recent papers have reported that the FERM domain 
containing tumor-suppressor protein Merlin/NF2 interacts indi-
rectly with the RBX1/Cul4 complex (Huang and Chen, 2008;   
Li et al., 2010). Moreover, other work has shown a link between 
Merlin and Rac (Shaw et al., 2001; Sherman and Gutmann, 2001; 
Xiao et al., 2002; Okada et al., 2005; Morrison et al., 2007). These 
reports led us to investigate the role of Merlin in our system. 
Western blots on HeLa cells depleted for RBX1 showed no sig-
nificant increase in the amount of Merlin protein (Fig. S1 B), in 
agreement with Huang and Chen (2008). Moreover, we were un-
able to detect a morphological or actin phenotype in S2R+ cells 
treated with independent dsRNAs targeting Drosophila Merlin 
(original fly screening data, and validated in Fig. S1 C), ruling out 
Merlin as the key link between the SCF complex and Rac.
Finally, to determine whether we could place Roc1a ge-
netically upstream or downstream of Rac1, we tested the effect 
of introducing activated RacV12-GFP into S2R+ cells in which 
the expression of Roc1a and slmb as representative SCF mem-
bers had been silenced using RNAi, compared with knockdown 
of SCAR as a representative SCAR complex member. In con-
trol cells, activated RacV12 causes a characteristic phenotype, 
namely a very spread cell with high levels of lamellipodial actin.   
As shown in Fig. 4 D, although RacV12 was unable to rescue the 
spiky  phenotype  of  SCAR  RNAi,  Roc1a-depleted  and  slmb- 
depleted cells positive for RacV12-GFP developed prominent 
lamellipodia. Similarly, in HeLa cells, an activated RacV12-myc 
construct was able to rescue RBX1 knockdown, but not that of 
Figure 5.  RBX1 depletion reduces active, GTP-bound Rac1. PAK-PBD bead pull-down of HeLa cell lysates depleted for control, RBX1, or Rac1 by siRNA, 
compared with the corresponding cellular lysate, probed with -Rac1. (A) The mean of three independent experiments, normalized to control levels, is 
shown. Error bars show standard deviation; B shows a representative blot. The reaction control samples, preloaded with GTPS and GDP (rightmost two 
lanes), were run in parallel but on a separate gel and membrane, as indicated.799 Screens define the conserved metazoan actinome • Rohn et al.
nuclear ribonucleoprotein particles (Cline et al., 1999). Snf was 
chosen as the representative example of the spliceosome com-
plex for further analysis. In addition, depletion of the transcrip-
tional regulator hyx/cdc73, which is a component of the Paf 
transcription complex (Shi et al., 1996), or of CG7597, which is 
the orthologue of mammalian Cdc2l5 known to regulate alter-
native splicing (Even et al., 2006), also produced a similar nu-
clear actin phenotype, as did the nuclear export gene Cas/CSE1 
segregation protein and CG17446.
When we tested the mouse orthologues of these Drosoph-
ila hits (Table I) by siRNA knockdown in a GFP-actin mouse 
fibroblast line R3A4, which are more amenable than HeLa cells 
to studying nuclear export (unpublished data), we found that the 
depletion of the Exp6 orthologue Xpo6 led to the clear accumu-
lation of nuclear GFP-actin, as expected (Fig. 6 C). In contrast, 
we found that depletion of the Cas orthologue Cse1l and the 
CG17446 orthologue Cxxc1 did not produce a nuclear actin 
phenotype  by  this  test,  and  depletion  of  the  snf  orthologue   
Snrpb2 was too toxic to assess the phenotype. However, silencing 
(Fig. 6 A), whereas fewer than 1% of control cells did so (Fig. 6 B). 
The identification of this phenotypic class was surprising given 
that F-actin in the nucleus in other systems has traditionally not 
been visible using the phalloidin stain (Vartiainen, 2008). How-
ever, Exp6 and chic were identified among this set, both of which 
were previously shown to be required for the nuclear export of 
globular actin (Fig. 6 A and B; Stüven et al., 2003), suggesting a 
mechanism by which these nuclear filaments might form. This 
result led us to follow up the analysis of the nuclear actin pheno-
typic cluster in both fly and mammalian cells.
From the set of 28 dsRNAs that initially gave rise to a nu-
clear actin phenotype, we chose to follow up 8 representatives, 
and reproducibly confirmed 6 of these as strong hits in S2R+ 
cells using two independent dsRNAs, including Exp-6 (Table I; 
note chic was primarily categorized due to its more dominant 
phenotype, “decreased actin”, but it also validated as a seventh 
nuclear actin gene). Notably, several of the hits we had initially 
identified were components of the spliceosome, including snf 
(sans fille), which is an integral component of U1 and U2 small 
Figure 6.  Novel genes regulate actin in the nucleus. (A) Images showing actin bars in the nucleus of S2R+ after gene depletion. Bar, 10 µm (B) Quantita-
tion of bars of experiment represented in A. (C) Depletion of key genes induces actin accumulation in mammalian cells. Red is F-actin, blue is DNA, and 
green is GFP-actin. Bar, 20 µm.JCB • VOLUME 194 • NUMBER 5 • 2011   800
functions  have  been  recently  described  (Katoh  and  Katoh, 
2003; Perdigoto et al., 2008; Han et al., 2009; Fabian et al., 
2010; Mersich et al., 2010; Mason et al., 2011). Instead, our 
hits fell into functional categories likely to act upstream of   
actin, such as specific splicing factors, nuclear export path-
ways, and proteasomal regulators. This highlights the impor-
tance of studying the regulation of actin dynamics in a wider 
cell-biological context (Pollard and Cooper, 2009), to which 
this and other unbiased functional screens can make an impor-
tant contribution. Intriguingly, several of these proved to be 
small genes (e.g., l(1)10Bb, CG13623, and Roc1a), which are 
often  missed  in  classical  genetics  screens.  Conversely,  the 
vast majority of unstudied genes with predicted actin-binding 
domains but no previously identified phenotype did not have 
an actin phenotype in our study. Some of these genes may 
simply have been missed due to inefficient silencing; how-
ever, it is likely that many of these proteins were effectively 
depleted by our reagents but were not morphological hits   
because they may have evolved more subtle tissue-specific   
actin-related  functions,  or  because  they  may  simply  act  as 
scaffolds to tether other processes to the actin cytoskeleton.
Among the basic cell processes upstream of actin regula-
tion revealed by our screen, ubiquitination mediated by the SCF 
complex emerged as a conserved regulator upstream of Rac-
mediated actin polymerization. Our phenotypic analysis of   
fly screen data suggests that Slmb/BTRC/-TrCP is the main   
F-box receptor required for this activity. Slmb is known to regu-
late  transcription  and  cyclin-dependent  kinases  (Frescas  and 
Pagano, 2008), but thus far no known roles for SCF/Slmb sug-
gest a link to cell shape and the actin cytoskeleton. It is possible, 
for example, that SCF/Slmb targets a Rac inhibitor for degrada-
tion, although we could detect no relevant phenotype in any of 
the known Rac inhibitors present in our screens. Further studies 
will be required to define the pathway in more detail.
In addition, the screen identified a set of dsRNAs that gave 
rise to a previously undescribed phenotype, the accumulation of 
phalloidin-stained nuclear actin bars. It has become increas-
ingly obvious that actin has many important functions in the cell   
nucleus, especially in the process of gene expression. For exam-
ple, nuclear actin has been implicated in the regulation of tran-
scription factor activity, in transcription by all three RNA 
polymerases, in chromatin remodeling, and in premRNA pro-
cessing (Skarp and Vartiainen, 2010). Despite these essential 
roles, very little is known about how nuclear actin is regulated. 
In our genome-wide fly screen, we identified several factors 
whose depletion caused accumulation of F-actin in the nucleus. 
These proteins are therefore candidates for regulators of nuclear 
actin export or proteins that limit inappropriate actin polymer-
ization within the nucleus. Both processes may be functionally 
significant, as recent studies have suggested that modulation of 
nuclear actin levels appears to correlate with cellular quiescence 
(Spencer et al., 2011), and functional studies point to a require-
ment  for  polymerized  actin  within  the  nucleus  for  this  role   
(McDonald et al., 2006; Ye et al., 2008). How nuclear actin lev-
els are regulated in cells remains poorly understood, although 
increased actin in the nucleus has been detected upon the induc-
tion of different cellular stresses (Vartiainen, 2008).
of the hyx orthologue Cdc73 and the CG7597 orthologue Cdc2l5 
resulted in a similar nuclear accumulation of GFP-actin (Fig. 6 C). 
These results suggest that, even though we were unable to see 
phalloidin-stained nuclear actin bars in these cells, the pathways 
regulating nuclear actin levels are at least partially conserved 
through evolution.
Cdc73, also known as parafibromin, is in humans encoded 
by the HRPT2 gene, mutations of which cause the hyperpara-
thyroidism-jaw tumor syndrome (Carpten et al., 2002). As a 
component of the Paf complex, Cdc73 is involved in many 
transcription-related processes, including communication with 
transcription  factors,  regulation  of  histone  modification,  and 
recruitment of premRNA processing factors (Jaehning, 2010). 
Accordingly, cells from Cdc73 knockout mice display altered 
gene expression profiles (Wang et al., 2008). Although Cdc73 
is mainly a nuclear protein (Bradley et al., 2007), it has also 
been found in the cytoplasm, where it may interact with the   
actin cross-linking proteins actinin-2 and actinin-3 (Agarwal   
et al., 2008). Cdc2l5 belongs to a subfamily of Cdc2-related   
kinases (Marqués et al., 2000), and is also called the cyclin- 
dependent kinase 13 (Cdk13) due to its ability to bind to L-type 
cyclins (Chen et al., 2007). It has been linked to alternative 
splicing (Even et al., 2006), and binds, for example, to the HIV-1 
Tat-protein to regulate viral mRNA splicing (Berro et al., 2008). 
It remains to be determined how these genes and the spliceo-
some function to regulate levels of nuclear actin.
In summary, we have used a genome-scale RNAi screen 
in fly cells and a secondary screen in mammalian cells to define 
a conserved actinome based upon phenotype. This includes a 
number of new conserved actin regulators and implicates sev-
eral  core  molecular  processes  in  the  regulation  of  the  actin   
cytoskeleton. This simple strategy could be applied to enhance 
our understanding of a wide range of cell biological processes.
Discussion
Many actin regulators have been characterized over the years in 
a variety of organisms, including cell- and species-specific regu-
lators, and a set of proteins that has subsequently proven to be 
functionally conserved. We were interested in using a system-
atic approach to define a core “actinome” based upon pheno-
type in cultured cells from two different lineages derived from 
two disparate animal species, Drosophila and mammals. This 
comparative screening strategy yielded four broad categories of 
hits: (1) the expected suite of proteins with well-known bio-
chemical functions related to actin (e.g., Arp2/3 complex, SCAR, 
Rac); (2) poorly studied proteins with predicted biochemical 
functions related to actin (e.g., CG32138/FMNL1, Sktl/PIP5KC); 
(3) proteins with known biochemical functions but little pre-
vious relationship to actin or its regulation (e.g., the ubiquitin   
ligase component Roc1a/RBX1, the cyclin-dependent kinase 
Hyx/Cdc73); and (4) genes encoding proteins with no known 
biochemical function but with a conserved actin phenotype in 
our screen (e.g., CG13623/ISCA2).
Our analysis failed to identify good candidates for novel 
proteins that alter actin filament dynamics through direct bind-
ing to actin aside from CG32138/FMNL1, whose actin-related 801 Screens define the conserved metazoan actinome • Rohn et al.
PCR product. pDoner-RacV12 was used for an LR reaction (Invitrogen) with 
the pMT-NT-GFP-destination vector (Liu et al., 2010) to create the final con-
struct. The sequence as well as the activating V12 point mutation was con-
firmed by sequence analysis.
Cell culture
HeLa-Kyoto human carcinoma cells were cultured at 37°C in a humidified 
incubator  under  5%  CO2  in  9-cm  dishes  in  DME  (Invitrogen)  supple-
mented with 10% fetal bovine serum (FBS, PAA) and antibiotics (50 U/ml 
penicillin and 50 µg/ml streptomycin; Invitrogen). Adherent S2R+ Dro-
sophila cells were cultured at 24°C in a humidified incubator in T25 
flasks in Shields and Sang M3 insect medium (Sigma-Aldrich) supple-
mented with FBS and antibiotics as for HeLa cells. A tetracyclin-inducible 
GFP-actin–expressing mouse fibroblast NIH3T3 cell line (R3A4) was cre-
ated using the T-REX system (Invitrogen) according to the manufacturer’s 
instructions. R3A4 cells were maintained in DME supplemented with 10% 
FBS, GlutaMAX (Invitrogen) and antibiotics, as for HeLa cells, at 37°C 
and 5% CO2. Blasticidin and Zeocin (InvivoGen) were added during 
passaging but omitted during transfection.
RNAi reagent design and synthesis
The genome-wide screen was performed at the Drosophila RNAi Screening 
Center (Harvard Medical School, Boston, MA) using a library of 21,306 
distinct dsRNAs (See Table S1 for primer details) targeting 12,061 protein-
coding genes. Because the library targets 88% of the genome, we would 
expect this dataset to contain phenotypic information for the vast majority 
of known actin regulators, along with phenotypes for previously uncharac-
terized  actin  regulators.  For  validation  experiments,  PCR  primers  were 
based on a genome-wide library purchased from Invitrogen/Ambion, the 
DRSC validation library (http://flyrnai.org), or designed de novo using 
SnapDragon (http://flyrnai.org/snapdragon_doc1.html; see Table S2 for 
details). Gene-specific amplicons (200–500 bp; average 400 bp) were am-
plified from genomic DNA by PCR using HotStart Taq polymerase (QIAGEN) 
with primer pairs synthesized to order (EuroGentec). RNA was synthesized 
using a MegaScript reverse transcription kit (Invitrogen), and purified using 
a Multiscreen HTS kit (Millipore) or NucAway spin column (Applied Bio-
systems), and annealed by heating at 65°C for 10 min then cooling slowly 
to room temperature. dsRNAs were quantified by NanoDrop spectrometry, 
and gel electrophoresis was used to confirm the integrity of the dsRNAs. 
dsRNAs were stored at 40°C until use.
For the human screens, we used a computational approach to nomi-
nate actin- and Rho GTPase–related genes to create the “actinome” library. 
The actinome library contained (1) genes with known actin cytoskeleton 
association; (2) genes with predicted actin-binding domains; and (3) Rho 
family GTPases, GAPs, and GEFs. We also determined the human ortho-
logues of Drosophila actin morphology hits by comparing orthologue as-
signments from Homologene (http://www.ncbi.nlm.nih.gov/homologene), 
Inparanoid (http://inparanoid.sbc.su.se/cgi-bin/index.cgi), and Ensembl 
(http://www.ensembl.org/index.html). Synthetic siRNAs for all target 
genes were obtained from Thermo Fisher Scientific/Dharmacon (Table S3). 
For controls, we included multiple instances of the following four Thermo 
Fisher Scientific controls: siCONTROL (a scrambled negative-control siRNA 
sequence); INCENP and KIF11, which give strong and distinctive pheno-
types; and siTOX, an siRNA reagent that induces cell death. All siRNAs 
were reconstituted in nuclease-free water in 1x buffer provided by the man-
ufacturer. For the mouse cell siRNA experiments, we purchased siRNA 
from QIAGEN and Sigma-Aldrich (Table S3).
High-throughput RNAi screening
The genome-wide S2R+ cell screen was performed as described previ-
ously (Kiger et al., 2003). In brief, a semi-automated method was used to 
seed 10 µl of a trypsinized suspension of S2R+ cells at a concentration 
of 2 × 10
6 cells/ml in serum-free M3 medium into black, thin-bottomed 
384-well tissue culture plates (Corning) already containing a 3-µl droplet 
of dsRNA (0.3 µg). After a 30-min incubation at room temperature, 
wells were supplemented with 30 µl of complete M3 medium. All manipu-
lations  were  performed  with  an  alcohol-sterilized  WellMate  liquid- 
handling robot inside a tissue culture hood. Plates were spun briefly, sealed 
with parafilm, and incubated in a 25°C humidified incubator for 5 d   
before being processed: using a semi-automated method with the Well-
Mate robot, cells were fixed with freshly prepared 4% formaldehyde in 
PBS for 20 min at room temperature, permeabilized with 0.2% Triton   
X-100 in PBS for 5 min, then blocked with 5% BSA in PBS for 30 min. 
Next, cells were stained with a mixture of FITC-conjugated anti–-tubulin 
antibody (clone DM1A at 1:400; Sigma-Aldrich), TRITC-conjugated phal-
loidin (0.125 µg/ml; Sigma-Aldrich), and DAPI (1 µg/ml; Sigma-Aldrich) 
Nuclear export of actin is mediated by the importin- 
family member Exportin-6, which seems to use the small actin-
binding protein profilin as a cofactor (Stüven et al., 2003). In 
our experiments in both fly and mammalian cells, depletion of 
either Exportin-6 or profilin resulted in the nuclear actin pheno-
type, demonstrating that our screen was sensitive enough to re-
cover known factors involved in this process. The polymerization 
status of actin in the nucleus is still somewhat unclear, but it is 
thought that the majority of nuclear actin would be monomeric 
(McDonald et al., 2006). Indeed, phalloidin does not generally 
stain the nucleus, and we did not observe phalloidin-stainable 
bars in mammalian cells. Nevertheless, several studies have sug-
gested a role for F-actin in the nucleus (Miyamoto et al., 2011) 
and S2R+ cells may therefore represent a good system in which 
to study this phenomenon.
Of note, many of the nuclear actin hits from Drosophila 
cells are components of the spliceosome. Although the spliceo-
some component we chose to validate in mouse cells, Snrpb2, 
could not be analyzed due to cell death, Cdc2l5, which pro-
duced the phenotype in both systems, has also been linked to 
splicing (Even et al., 2006). How defects in spliceosome func-
tion result in the nuclear actin phenotype is presently unclear, 
but it may be due to altered expression of proteins required for 
nuclear export of actin, or to a general stress response in the 
cell, as this has been shown to increase nuclear actin levels 
(Welch and Suhan, 1985). Alternatively, actin itself has been 
implicated in premRNA processing, and binds directly to sev-
eral hnRNP proteins (Percipalle et al., 2002) that play a key role 
in this process. Perhaps disruption of the splicing process re-
leases actin from these factors, resulting in uncontrolled actin 
polymerization within the nucleus. Future studies will reveal at 
which stage the identified factors impinge on nuclear actin to 
regulate its nuclear export and/or polymerization properties.
In summary, our species-comparative approach, as exem-
plified by the Rac/SCAR cluster and the actin-in-the-nucleus 
cluster, revealed that entire functional modules can be recapitu-
lated across species, and that such “phenoprinting” can be used 
as a powerful shortcut to find novel actin regulators. Even when 
the  precise  nature  or  appearance  of  phenotype  itself  is  not   
always conserved between species (e.g., a spiky appearance in 
S2R+ cells versus a triangular, stress-fiber appearance in HeLa 
cells; or the phalloidin stainable bar in S2R+ versus actin accu-
mulation in mouse cells), consistent phenoprints within a spe-
cies can still be used to pinpoint conserved functional modules. 
By making our data freely available, we expect that they can be 
further mined by the community for functional pathways tai-
lored to individual laboratory interests, and as such should serve 
as an important resource for the future.
Materials and methods
Recombinant DNA cloning
We constructed pMT-RacV12 from a preexisting pUAS-RacV12 plasmid 
template using PCR with oligo Rac1(NT_BP) forward (5-GGGGACAAGTTT-
GTACAAAAAAGCAGGCTTCGAAGGAGATAGAACCATGGATGCAGGC-
GATCAAGTGCGTCG-3) and Rac1(NT_BP) reverse (5-GGGACCACTTT-
GTACAAGAAAGCTGGGTCTTAGAGCAGGGCGCACTTGCGC-3). The 
PCR amplimer was gel purified (QIAGEN), then a BP Clonase (Invitrogen) 
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plastic tissue culture plate) and mixed these with 3 µg of dsRNA corre-
sponding to the gene of interest or, as a negative control, to dsRNA target-
ing LacZ or dsRed, whose sequences are not present in the fly genome. 
This mixture was incubated at 24°C for 30 min before addition of complete 
serum-containing medium (300 µl). Cells were grown for 3–7 d at 24°C, 
depending on the experiment, then replated onto FBS- or Con A–coated 
circular 13-mm-diam coverslips and allowed to spread before analysis 
(typically 1–3 h). In experiments where cells were not replated before analy-
sis (e.g., validating the nuclear actin hits in S2R+ cells), cell seeding 
was slightly different: 50,000 cells in 200 µl directly onto coverslips in a   
24-well plate, analyzed after 6 d.
For  experiments  requiring  plasmid  transfection,  S2R+  cells  were 
transfected in 4-well plates with 1 ug total of DNA using FugeneHD (Roche), 
following the manufacturer’s protocol. We used GFP-tagged RacV12   
under the control of a metallothionein promoter (pMT), or as a negative 
control, pMT-Gal4. 18 h before processing the experiments, a copper sul-
phate solution was added to the medium (final concentration, 70 nM) to in-
duce expression from the pMT promoter.
For human cell validation, our strategy was to repeat the screen 
twice and to use pools as well as individual siRNAs for depletion, so on 
average each gene was tested five different ways in two separate sessions. 
We relied upon independent siRNAs and not pools for validation because 
75 genes of the 116 hits failed to display a phenotype when using the pool 
in a situation when two or more of its individual siRNA components had a 
positive, gene-consistent phenotype. This result was likely due in part to 
dosage effects, as we kept the overall concentration of siRNA constant for 
all conditions, meaning that on average, each single siRNA was present at 
four times the concentration of its pool counterpart.
Small-scale HeLa experiments were performed in 384-well plates or 
by scaling up appropriately into 8-well chamber slides (LabTek; Thermo 
Fisher  Scientific)  precoated  with  fibronectin  (10  µg/µl  in  PBS;  Sigma- 
Aldrich). We used Thermo Fisher Scientific siCONTROL as a negative con-
trol in all cases. When plasmid transfection of RNAi cultures was required, 
FugeneHD was used as for S2R+ cells together with a myc-tagged RacV12 
construct (Hogan et al., 2009) or as a negative control, a histone-2B-RFP 
construct, 18 h before processing. For experiments with mouse R34A cells, 
5,000 cells were seeded on coverslips in a 24-well plate overnight. Cells 
were transfected with 10 nM siRNA using Interferin siRNA transfection re-
agent (Polyplus). After transfection, cells were incubated at 37°C with 5% 
CO2 for 4 d before induction of GFP-actin expression with 1 µg/ml tetra-
cycline for 24 h, and were then analyzed. A GFP-alone construct was used 
as a negative control.
For immunostaining, all cell types were fixed and permeabilized as 
described for screening (except we used 4% paraformaldehyde instead of 
formaldehyde for the nuclear DNA experiments). For some experiments, 
wells that had received tagged RacV12 constructs were stained with the 
same mix, except DM1A-stained cells were visualized using a goat anti–
mouse immunoglobulin antibody conjugated to Alexa 647 (1:500; Invitro-
gen); GFP signal was bolstered using anti-GFP antibody (Invitrogen), and 
myc-tagged-RacV12 was visualized using -Myc tag (Clone 4A6; Milli-
pore). For experiments assessing the presence and localization of GTP-
bound Rac1, we used the monoclonal antibody -Active Rac1 (NewEast 
Biosciences)  at  a  concentration  of  1:200.  For  HeLa  cells,  slides  were 
mounted in FluorSave Reagent (EMD) and imaged using a scanning con-
focal microscope (model SP5, Leica; either the 40x lens or the 63x oil lens, 
NA 1.25 and 1.4, respectively;). For mouse cells, we used a confocal   
microscope (TCS SP5 MP SMD FLIM; Leica) equipped with a 63x (NA 1.3) 
oil objective. For both Leica microscopes, LAS AF software (Leica) was 
used for image acquisition. For fly cell experiments in which we were   
assessing phalloidin-stainable bars in the nucleus, actin was visualized 
with Alexa Fluor 594–conjugated phalloidin (Invitrogen) instead of TRITC-
phalloidin, slides were mounted with Moviol-DABCO (Sigma-Aldrich), and   
images  were  acquired  using  a  microscope  (AX70  Provis;  Olympus) 
equipped with an Plan Apochromat 60x, NA 1.40 oil objective. The cam-
era used was F-view II FW (Olympus), and images were acquired with the 
analySIS software (Olympus).
All  images  were  processed  according  to  good  practice  using   
ImageJ/FIJI or Photoshop; in some cases we altered the brightness and 
contrast of the entire image to improve the image. Color channels were 
merged using either ImageJ or Photoshop.
Western blot analysis and GTP-bound Rac1 pull-down assays
For Western blotting to inspect SCAR complex stability, we either lysed 
samples directly in 2x Laemmli buffer (Sigma-Aldrich) and disrupted them 
with a fine-gauge needle, or lysed them in ice-cold RIPA buffer (50 mM 
Hepes, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 
in a PBS solution containing 1% BSA for 1 h. After 4x washing with PBS, 
plates were sealed with adhesive foil and stored in PBS containing 0.1% 
sodium azide (Sigma-Aldrich). Images were acquired using a 20x objec-
tive lens (NA 0.45) on a modified Eclipse TE-2000E microscope (Nikon) 
equipped with a Prior Proscan motorized stage and MetaMorph software 
(Molecular Devices), autofocusing on the DAPI channel. Images were 
screened visually using the MetaMorph “Review Screen Data” applica-
tion. The uploaded .tif files were converted from 16-bit to 8-bit but were 
otherwise unprocessed.
The fly cell screen was performed once, and three independent re-
searchers visually inspected images captured from two sites per well to 
nominate potential hits with morphology phenotypes of any description. 
We filtered the set of nominated hits to exclude dsRNAs with (1) >1 pre-
dicted amplicon; (2) one or more CAN repeats (a stretch of a particular tri-
nucleotide sequence [CAn] repeated five or more times, which is known to 
cause nonspecific effects (Echeverri et al., 2006)); (3) >5 predicted off-target 
effects (19 bp; Echeverri et al., 2006); and (4) no known protein-encoding 
gene target according to FlyBase version 5.23 (http://flybase.org; Table S1). 
Images from the remaining dsRNAs were then annotated using a controlled 
vocabulary to describe phenotypes affecting cell number, cell size, and all 
aspects of nuclear and cytoskeletal morphology. DsRNAs with weak or in-
consistent phenotypes (defined as present in only one of the two sites) were 
excluded from this analysis. In inspecting this refined list of dsRNAs associ-
ated with morphological phenotypes (see hit annotation details in Table 
S2), we found that when multiple dsRNAs targeting the same gene were 
annotated as hits, a similar range of phenotypes was recorded, demon-
strating the robustness of the method.
For  HeLa  cell  screens,  siRNAs  were  arrayed  into  the  Corning 
screening plates at a final concentration of 0.5 µM (3 µl) using both indi-
vidual siGENOME duplexes and SmartPools (Thermo Fisher Scientific) 
using  a  Biomek  Fx  robotic  liquid-handling  robot  (Beckman  Coulter), 
sealed with foil adhesives and stored at 40°C until use. Trypsinized 
HeLa cells (2,000 cells per well) without antibiotics were reverse trans-
fected with Lipofectamine 2000 (Invitrogen) according to the manufactur-
er’s instructions at a final volume of 80 µl (final siRNA concentration of 
25 nM). All transfection manipulations were performed sterilely as de-
scribed for S2R+ cells, and the plates were spun briefly to eliminate any 
bubbles and incubated at 37°C in a humidified incubator under 5% CO2 
for 3 d before processing as for the fly screen. Each human gene was tar-
geted using four independent siRNAs, each individually assessed in four 
separate wells, and, for genes in the actinome, with the addition of a fifth 
well containing those four siRNAs pooled together. The entire screen was 
performed  in  duplicate,  and  images  (three  sites  per  well)  from  both 
screens were loaded into FLIGHT. Images were annotated by two inde-
pendent researchers blinded to well designations; although we assessed 
the same general phenotypic categories as with the fly screen, we used 
more  extensive  sub-descriptions  to  reflect  the  greater  detail  visible  in 
these cells. Genes were considered hits if at least two independent siRNA 
constructs were identified as strong morphological hits with similar phe-
notypes in both screen replicates by both researchers.
Hierarchical clustering and network analysis
We performed hierarchical clustering of both Drosophila and human bi-
nary  RNAi  phenotype  annotations  using  the  correlation  distance  and 
Wards method using R (http://www.r-project.org). To identify related hits 
that formed part of the same complex or interaction group, we used the 
network analysis tool on the FLIGHT database, which queries interaction 
data from a large set of online databases including Reactome and BioGrid 
(Sims et al., 2006, 2010).
Morphological phenotype validation
For validation experiments, we delivered dsRNAs to S2R+ cells in a similar 
manner as the high-throughput protocol and incubated them for 6 d. This 
longer incubation ensured that all phenotypes had time to manifest. Under 
these conditions, for example, we also validated the remaining four 
Arp2/3 complex components (Arc-p34, Arpc3a, Arpc3b and Arc-p20) 
that were not identified as hits initially because these proteins have a low 
turnover (Kunda et al., 2003). Cells were then trypsinized and replated at 
a lower density into two black, thin-bottomed confocal-ready 384-well tis-
sue culture plates (Greiner bio-one)—one whose wells had been precoated 
overnight at 37°C with FBS, the other coated with concanavalin A (Con A 
IV-S; Sigma-Aldrich), dissolved at 5 µg/ml in water. Cells were allowed   
to spread for 1–3 h and then fixed. We also fixed replicates in which the   
cells were not replated after RNAi. For RNAi experiments destined to be 
replated onto glass coverslips, we suspended cells in serum-free medium at 
a concentration of 2 × 10
6 cells/ml (100 µl droplet in a well of a 4-well 803 Screens define the conserved metazoan actinome • Rohn et al.
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made them up to 1x Laemmli buffer. All samples were heated at 99°C for 
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(Invitrogen) for the Rac pull-down assay (see the next paragraph). We 
then transferred proteins to Immobilon-P (Millipore) membrane by Western 
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LEBS Centre National de la Recherche Scientifique, Gif-sur-Yvette, Paris, 
France); 1:1,000 for the human NF2/Merlin antibody (B12; Santa Cruz 
Biotechnology, Inc.); 1:1,500 for the WAVE2/WASF2 antibody (Gautreau 
et al., 2004); 1:2,000 for the dPak3 antibody (Asano et al., 2009); 
1:2,000 for the -tubulin antibody (DM1A; Sigma-Aldrich); and 1:2,000 
for the anti-cdc2 antibody (anti-PSTAIR; Sigma-Aldrich), and then washed 
five times with TBS-T. We next incubated membranes with the appropriate 
HRP-conjugated secondary antibodies (1:1,000; Dako) in TBS-T for 1 h, 
and washed them as before, followed by an ECL procedure and detection 
on either Hyperfilm EC or an ImageQuant LAS4000 (solutions, film, and 
apparatus all from GE Healthcare). When reprobing was required, we 
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ing and reblocking as normal. Protein bands were quantified on unsatu-
rated  exposures  using  the  ImageQuantTL  software  according  to  the 
manufacturer’s instructions.
For assessing the activity state of Rac1 biochemically in HeLa cells, 
we scaled up the siRNA transfection to 9-cm plates (2.6 × 10
6 cells 18 L 
Lipofectamine 2000 and 12 µl of siRNA [stock: 20 µM] in a total of 4 ml). 
The media was changed the next day, and 3 d after transfection with 
siRNA, when cultures were less than 50% confluent, we trypsinized the 
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altered by the siCONTROL or RBX1 siRNA treatments.
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